Programs
The eight major programs and investigators which form the core of the GCRC are as follows:
- Recombinant Idiotype Vaccines for the Immunotherapy of Follicular Non-Hodgkin's Lymphomas (R. Levy),
- Clinical Trials in HIV Positive Patients (T. Merigan),
- Surgery for Necrotizing Enterocolitis in Human Infants (L. Moss),
- Studies of Hypothalamic-Pituitary-Adrenal Axis in Psychotic Depression (A. Schatzberg),
- A Phase I Study of ZD1839 (Iressa) in Combination with Oxaliplatin, 5-Fluorouracil, and Leucovorin in Advanced Solid Malignancies (B. Sikic),
- Clinical Experiment of H-Pylori Transmission (J. Parsonnet),
- Pathophysiology of Hepatorenal Syndrome (B. Myers) and
- Gene Therapy for Hemophilia (M. Kay and B. Glader).
Other current projects include:
- Coronary Heart Disease Risk Factors in Patients with Noninsulin Dependent Diabetes
- Genetic Determinants of Human Hypertension
- HPA Axis/Dopamine Interactions in Psychotic Depression
- Influence of Dietary Intervention on Survival of Women with Breast Cancer
- Transcranial Doppler Monitoring of Microemboli in Patients with Mechanical Heart Valve Replacements
- Radioimmunotherapy of Cancers
- Prevention of Type I Diabetes, and
- Effects of Smoking Cessation on Vascular Reactivity
